Evaluation of the effectiveness of Q-Switched ND:YAG laser in the treatment of facial skin lesions

Evaluation of the efficacy and side effects of fractional Q-Switched ND:YAG laser in the treatment of ophthalmia in patients

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20080901001159N31

Enrollment

Registered

2021-01-10

Start date

2020-08-22

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye dark circles. -

Interventions

Intervention group: Patients receive 6 fractions of treatment with 2 weeks interval (3 months in total) by QS Nd-yag laser. At each turn is done, two passes of 1000 joules on the peri-orbital areas..

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The cause of darkness, structural and reducing fat in this area is not Age between 18 and 65 years old

Exclusion criteria

Exclusion criteria: Active infection in the face Pregnancy and breastfeeding History of cancer

Design outcomes

Primary

Measure	Time frame
Preorbital hyperpigmentation. Timepoint: Session 0, 4 and 6 during treatment and 3 months after treatment. Method of measurement: Intensity of the darkening of the skin around the eyes compared to other areas of the face with Mexameter device.;Satisfaction amount. Timepoint: After completion of treatment. Method of measurement: Comparison of reduction preorbital hyper pigmentation by patient , before and after treatment According to schedule ( score 0 to 10 ).	—

Measure

Time frame

Preorbital hyperpigmentation. Timepoint: Session 0, 4 and 6 during treatment and 3 months after treatment. Method of measurement: Intensity of the darkening of the skin around the eyes compared to other areas of the face with Mexameter device.;Satisfaction amount. Timepoint: After completion of treatment. Method of measurement: Comparison of reduction preorbital hyper pigmentation by patient , before and after treatment According to schedule ( score 0 to 10 ).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShiva Alavi

Skin and Stem cell Research Center of Tehran University of Medical Sciences

Shiva.alavi@yahoo.com+98 21 2220 1710

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026